N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride

C14H26ClN3O3 — CID 119741950

IUPACN-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride
SMILESCl.O=C(CCNC(=O)C1CNCCO1)NC1CCCCC1
InChIInChI=1S/C14H25N3O3.ClH/c18-13(17-11-4-2-1-3-5-11)6-7-16-14(19)12-10-15-8-9-20-12;/h11-12,15H,1-10H2,(H,16,19)(H,17,18);1H
InChIKeyARXALFAVHYIOKX-UHFFFAOYSA-N
MW319.83 g/mol
LogP0.35
Rot. Bonds5

About N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride

N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride (PubChem CID 119741950) has the molecular formula C14H26ClN3O3 and a molecular weight of 319.83 g/mol. Its IUPAC name is N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride.

Molecular Properties

Compound NameN-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride
PubChem CID119741950
Molecular FormulaC14H26ClN3O3
Molecular Weight319.83 g/mol
Exact Mass319.17
IUPAC NameN-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride
SMILESCl.O=C(CCNC(=O)C1CNCCO1)NC1CCCCC1
InChIInChI=1S/C14H25N3O3.ClH/c18-13(17-11-4-2-1-3-5-11)6-7-16-14(19)12-10-15-8-9-20-12;/h11-12,15H,1-10H2,(H,16,19)(H,17,18);1H
InChIKeyARXALFAVHYIOKX-UHFFFAOYSA-N
XLogP0.35
TPSA79.46 Ų
H-Bond Donors3
H-Bond Acceptors4
Rotatable Bonds5
Heavy Atoms21
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500319.83
LogP ≤ 50.35
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 104

Analyze N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

(2S)-N-cyclopentylmorpholine-2-carboxamide
CID 92614945
N-(3-cyclohexylpropyl)morpholine-2-carboxamide;hydrochloride
CID 119724280
N-(2-cycloheptyloxyethyl)morpholine-2-carboxamide;hydrochloride
CID 119786670
(2R,3S)-N-[3-(cyclohexylamino)-3-oxopropyl]-2-methylmorpholine-3-carboxamide;hydrochloride
CID 120926749
N-[2-(cyclopropanecarbonylamino)ethyl]morpholine-2-carboxamide;hydrochloride
CID 119687765
N-(3-oxo-3-piperidin-1-ylpropyl)morpholine-2-carboxamide
CID 112701632
N-(3-cyclopentylpropyl)morpholine-2-carboxamide
CID 113266264
N-[3-(cyclohexylamino)-3-oxopropyl]pyrrolidine-2-carboxamide;hydrochloride
CID 119299488
N-cycloheptyl-2-morpholin-2-ylacetamide
CID 66434351
(2S)-N-(cyclobutylmethyl)morpholine-2-carboxamide;hydrochloride
CID 131065842
N-(5-piperidin-1-ylpentyl)morpholine-2-carboxamide;dihydrochloride
CID 119885469
(2R)-N-(azetidin-3-ylmethyl)morpholine-2-carboxamide;hydrochloride
CID 130702713

Frequently Asked Questions

What is the IUPAC name of N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride?
The IUPAC name of N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride (CID 119741950) is N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride.
What is the SMILES notation for N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride?
The canonical SMILES for N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride is Cl.O=C(CCNC(=O)C1CNCCO1)NC1CCCCC1.
What is the InChIKey of N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride?
The InChIKey is ARXALFAVHYIOKX-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H25N3O3.ClH/c18-13(17-11-4-2-1-3-5-11)6-7-16-14(19)12-10-15-8-9-20-12;/h11-12,15H,1-10H2,(H,16,19)(H,17,18);1H.
What are the key properties of N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride?
N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride has a molecular weight of 319.83 g/mol, XLogP of 0.35, 5 rotatable bonds, 3 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(cyclohexylamino)-3-oxopropyl]morpholine-2-carboxamide;hydrochloride is sourced from PubChem (CID 119741950), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).